The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor

被引:101
作者
Ai, JH
Smith, P
Wang, SW
Zhang, P
Zheng, XL
机构
[1] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1074/jbc.M505513200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ADAMTS13 limits platelet-rich thrombosis by cleaving von Willebrand factor at the Tyr(1605)-Met(1606) bond. Previous studies showed that ADAMTS13 truncated after spacer domain remains proteolytically active or hyperactive. However, the relative contribution of each domain within the proximal carboxyl terminus of ADAMTS13 in substrate recognition and specificity is not known. We showed that a metalloprotease domain alone was unable to cleave the Tyr-Met bond of glutathione S-transferase (GST)-VWF73-H substrate in 3 h, but it did cleave the substrate at a site other than the Tyr-Met bond after 16-24 h of incubation. Remarkably, the addition of even one or several proximal carboxyl-terminal domains of ADAMTS13 restored substrate specificity. Full proteolytic activity, however, was not achieved until all of the proximal carboxyl-terminal domains were added. The addition of TSP1 2-8 repeats and two CUB domains did not further increase proteolytic activity. Furthermore, ADAMTS13 truncated after the spacer domain with or without metalloprotease domain bound GST-VWF73-H with a K-d of approximate to 7.0 or 13 nM, comparable with full-length ADAMTS13 (K-d = 4.6 nM). Metalloprotease domain did not bind GST-VWF73-H detectably, but the disintegrin domain, first TSP1 repeat, Cys-rich domain, and spacer domain bound GST-VWF73-H with Kd values of 489, 136, 121, and 108 nM, respectively. These proximal carboxyl-terminal domains dose-dependently inhibited cleavage of fluorescent resonance energy transfer (FRETS)-VWF73 by full-length ADAMTS13 and ADAMTS13 truncated after the spacer domain. These data demonstrated that the proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for recognition and cleavage of von Willebrand factor between amino acid residues Asp(1595) and Arg(1668).
引用
收藏
页码:29428 / 29434
页数:7
相关论文
共 34 条
[1]   Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency [J].
Assink, K ;
Schiphorst, R ;
Allford, S ;
Karpman, D ;
Etzioni, A ;
Brichard, B ;
van de Kar, N ;
Monnens, L ;
van den Heuvel, L .
KIDNEY INTERNATIONAL, 2003, 63 (06) :1995-1999
[2]   THE CUB DOMAIN - A WIDESPREAD MODULE IN DEVELOPMENTALLY-REGULATED PROTEINS [J].
BORK, P ;
BECKMANN, G .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 231 (02) :539-545
[3]   Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains [J].
Cal, S ;
Obaya, AJ ;
Llamazares, M ;
Garabaya, C ;
Quesada, V ;
López-Otín, C .
GENE, 2002, 283 (1-2) :49-62
[4]   ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor [J].
Dong, JF ;
Moake, JL ;
Bernardo, A ;
Fujikawa, K ;
Ball, C ;
Nolasco, L ;
López, JA ;
Cruz, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (32) :29633-29639
[5]   ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions [J].
Dong, JF ;
Moake, JL ;
Nolasco, L ;
Bernardo, A ;
Arceneaux, W ;
Shrimpton, CN ;
Schade, AJ ;
McIntire, LV ;
Fujikawa, K ;
López, JA .
BLOOD, 2002, 100 (12) :4033-4039
[6]   Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family [J].
Fujikawa, K ;
Suzuki, H ;
McMullen, B ;
Chung, D .
BLOOD, 2001, 98 (06) :1662-1666
[7]   Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura [J].
Furlan, M ;
Robles, R ;
Solenthaler, M ;
Lämmle, B .
BLOOD, 1998, 91 (08) :2839-2846
[8]   Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis [J].
Furlan, M ;
Robles, R ;
Lammle, B .
BLOOD, 1996, 87 (10) :4223-4234
[9]   Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura [J].
Furlan, M ;
Lämmle, B .
BAILLIERES CLINICAL HAEMATOLOGY, 1998, 11 (02) :509-514
[10]   Partial amino acid sequence of purified von Willebrand factor-cleaving protease [J].
Gerritsen, HE ;
Robles, R ;
Lämmle, B ;
Furlan, M .
BLOOD, 2001, 98 (06) :1654-1661